BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Feb 15, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-12-31

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-31	Common Stock	A	162	$69.777	Acquired	57600	Direct

Footnotes

F1: Represents shares acquired by the reporting person on October 31, 2017, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 34,078 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) include 57 shares inadvertently excluded in prior reports based on a reconciliation with the Company's records.